MIRA INFORM REPORT

 

 

Report Date :

12.11.2014

 

IDENTIFICATION DETAILS

 

Name :

JANANI PHARMACEUTICALS PRIVATE LIMITED

 

 

Registered Office :

217, Defence Officers Colony, Nandambakkam, Ekkaduthangal, Chennai - 600097, Tamilnadu

 

 

Country :

India

 

 

Financials (as on) :

31.03.2013

 

 

Date of Incorporation :

01.06.2001

 

 

Com. Reg. No.:

18-047192

 

 

Capital Investment / Paid-up Capital :

Rs.2.071 Millions

 

 

CIN No.:

[Company Identification No.]

U51397TN2001PTC047192

 

 

TIN No.:

Not Available

 

 

IEC No.:

Not Available

 

 

TAN No.:

[Tax Deduction & Collection Account No.]

CHEJ03250C

 

 

PAN No.:

[Permanent Account No.]

AAACJ9878L

 

 

Legal Form :

Private Limited Liability Company

 

 

Line of Business :

Trading in Bulk Drugs and Pharmaceuticals Products.

 

 

No. of Employees :

15 (Approximately)

 

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba (47

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Maximum Credit Limit :

USD 16900000

 

 

Status :

Satisfactory

 

 

Payment Behaviour :

Usually Correct 

 

 

Litigation :

Clear

 

 

Comments :

Subject is an established company having satisfactory track record.

 

Financial position of the company seems to be decent.

 

Trade relations are reported as fair. Business is active. Payment terms are reported to be usually correct.

 

The company can be considered for business dealings at usual trade terms and conditions.

 

NOTES:

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

 

ECGC Country Risk Classification List – June 1, 2014

 

Country Name

Previous Rating

(31.03.2014)

Current Rating

(01.06.2014)

India

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

 

INDIAN ECONOMIC OVERVIEW

 

N E W S

 

Verdict Implications: Apex court order may alter coal import dynamics. Traders go slowly on talks over coal supply contracts, uncertainty over cancellation of blocks weigh on stocks.

 

Recent arrest of the Chennai head of the Registrar of Companies, the ministry of corporate affairs arm that ensures that companies file all the information required by the Companies Act is the latest manifestation of a messy fight between a father and his adopted son for the control of Rs 40000 mn Business Empire. The Central Bureau of Investigation arrested Manumeethi Cholan after he accepted Rs 10 lakhs as bribe from M a M Ramaswamy, a CBI official said.

 

Central Bureau of Investigation books Electrotherm for cheating Central Bank of Rs 4360 mn.

 

Infosys maintains revenue guidance. COO Rao says attrition still an area of concern and it would take a few more quarters to bring down levels to 13-15 %.

 

DHL to invest Euro 100 mn in India over next 2 years. The firm has chosen India to pilot its e-commerce business model for the Asia-Pacific region.

 

Blackstone may buy stake in BlueRidge SEZ in line with the fund’s real estate strategy in India.

 

Kingfisher Airlines Ltd grounded in October 2012 under the weight of heavy debt and accumulated losses, recently approached the Delhi high court for relief in two separate cases. The airline challenged a notice by Punjab & National Bank alleging that it had wilfully defaulted on Rs 7700 mn of loans and sought more time to comply with the requirements under the listing agreements with the Stock Exchanges.

 

OnMobile likely to sack another 300 employees. The lay-offs follow a spate of senior-level exits over the past two years, starting with of its founder. The overall lay-offs could number around 600 and are driven by the need to cut costs, says a former employee.

 


 

EXTERNAL AGENCY RATING

 

NOT AVAILABLE

 

 

RBI DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available RBI Defaulters’ list.

 

 

EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of 31-03-2014.

 

 

INFORMATION PARTED BY (GENERAL DETAILS)

 

Name :

Mr. Kumar

Designation :

Admin Department

Contact No.:

91-9840706272

Date :

11.11.2014

 

 

LOCATIONS

 

Registered Office / Warehouse :

217, Defence Officers Colony, Nandambakkam, Ekkaduthangal, Chennai - 600097, Tamilnadu, India

Tel. No.:

91-44-65392500

Mobile No.:

91-9840706272 (Mr. Kumar)

Fax No.:

 

E-Mail :

jananipharmaceuticals@gmail.com

admin@jananipharma.com

info@jananipharma.com

Website :

http://www.jananipharmaceuticals.com

Location :

Rented

 

 

DIRECTORS

 

As on 30.09.2013

 

Name :

Mr. Raghhunaathan Ramaswamy

Designation :

Director

Address :

New No.4 A, Old No. 849, 91st Street, 13th Sector, K.K. Nagar, Chennai - 600078, Tamilnadu, India 

Date of Birth/Age :

11.05.1952

Date of Appointment :

01.06.2007

DIN No.:

01819909

Other Directorship:

S.

No.

CIN/LLPIN

Name of the Company/ LLP

Current designation of the Director/ Designated Partner

Date of appointment at current designation

Original date of appointment

Date of cessation

Company/ LLP Status

Defaulting status

1

U24239TN2003PTC050810

DR. ARS INDIA LABS PRIVATE LIMITED

Director

02/05/2003

02/05/2003

28/03/2007

Active

NO

2

U51397TN2001PTC047192

JANANI PHARMACEUTICALS PRIVATE LIMITED

Director

01/06/2007

01/06/2007

-

Active

NO

3

U24232PY2009PTC002373

DAEIOU PHARMACEUTICALS PRIVATE LIMITED

Director

21/10/2009

21/10/2009

-

Active

NO

 

 

Name :

Mr. Rada Ragunathan

Designation :

Director

Address :

N.No.4 A.O.No.849.91st Street, 13th Sector K K Nagar, Chennai - 600078, Tamilnadu, India 

Date of Birth/Age :

28.05.1958

Date of Appointment :

01.06.2001

DIN No.:

01820874

 

 

KEY EXECUTIVES

 

Name :

Mr. Kumar

Designation :

Admin Department

 

 

MAJOR SHAREHOLDERS

 

As on 30.09.2013

 

Names of Shareholders

No. of Shares

% of Holding

Raghhunaathan Ramaswamy

60330

29.14

Rada Ragunathan

98170

47.41

R Jagannathan

21500

10.38

R Sribargav

15567

7.52

K Sedarsas

11500

5.55

Total

207067

100.00

 

 

 

 

Equity Share Break up (Percentage of Total Equity)

 

As on 30.09.2013

 

Category

Percentage

Directors or relatives of Directors

100.00

Total

100.00

 

 

BUSINESS DETAILS

 

Line of Business :

Trading in Bulk Drugs and Pharmaceuticals Products.

 

 

Products :

  • Bulk Drugs
  • Pharmaceuticals Products

 

 

Brand Names :

--

 

 

Agencies Held :

--

 

 

Exports :

Not Available  

 

 

Imports :

Not Available  

 

 

Terms :

 

Selling :

Cash and Credit

 

 

Purchasing :

Cash and Credit

 

 

PRODUCTION STATUS – NOT AVAILABLE

 

 

GENERAL INFORMATION

 

Suppliers :

Not Divulged 

 

 

Customers :

Not Divulged 

 

 

No. of Employees :

15 (Approximately)

 

 

Bankers :

ICICI Bank Limited, New No. 69, Old No.13 A, Jawaharlal Nehru Road, Ekkatuthangal, Chennai, Tamilnadu - 600032, India

 

 

Facilities :

SECURED LOANS

31.03.2013

Rs. In Millions

31.03.2012

Rs. In Millions

SHORT TERM BORROWINGS

 

 

Loans repayable on demand

 

 

From bank

9.593

16.681

From ICICI loan for construction

2.876

0.000

Total

12.469

16.681

 

 

 

Banking Relations :

--

 

 

Auditors :

 

Name :

GHG Associates

Chartered Accountants

Address :

New No.22 (Old No.20), Govindu Street, T. Nagar, Chennai – 600017, Tamilnadu, India

Tel. No.:

91-44-28155757

E-Mail :

Ca.ccganesh@gmail.com

hareshauditor@gmai.com

PAN No.:

AAXPH0762M

 

 

Memberships :

--

 

 

Collaborators :

--

 

 

Related Parties :

  • Daeiou Pharmaceuticals Private Limited
  • Arien RR Impex 
  • Ace Pack
  • Narsing Invent Industrial Chemical
  • Narsing Pharma

 


 

CAPITAL STRUCTURE

 

As on 30.09.2013

 

Authorised Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

250000

Equity Shares

Rs.10/- each

Rs.2.500 Millions

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

207067

Equity Shares

Rs.10/- each

Rs.2.071 Millions

 

 

 

 


FINANCIAL DATA

[all figures are in Rupees Millions]

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

 

31.03.2013

31.03.2012

31.03.2011

I.              EQUITY AND LIABILITIES

 

 

 

(1)Shareholders' Funds

 

 

 

(a) Share Capital

2.071

1.900

1.900

(b) Reserves & Surplus

57.244

44.275

36.340

(c) Money received against share warrants

0.000

0.000

0.000

 

 

 

 

(2) Share Application money pending allotment

0.000

0.967

0.467

Total Shareholders’ Funds (1) + (2)

59.315

47.142

38.707

 

 

 

 

(3) Non-Current Liabilities

 

 

 

(a) long-term borrowings

0.000

0.000

19.516

(b) Deferred tax liabilities (Net)

0.000

0.000

0.000

(c) Other long term liabilities

0.000

0.000

0.000

(d) long-term provisions

0.000

0.000

0.000

Total Non-current Liabilities (3)

0.000

0.000

19.516

 

 

 

 

(4) Current Liabilities

 

 

 

(a) Short term borrowings

12.469

16.681

0.571

(b) Trade payables

149.392

132.002

139.455

(c) Other current liabilities

17.401

12.902

8.149

(d) Short-term provisions

13.663

7.869

7.166

Total Current Liabilities (4)

192.925

169.454

155.341

 

 

 

 

TOTAL

252.240

216.596

213.564

 

 

 

 

II.            ASSETS

 

 

 

(1) Non-current assets

 

 

 

(a) Fixed Assets

 

 

 

(i) Tangible assets

31.096

26.835

27.750

(ii) Intangible Assets

0.000

0.000

0.000

(iii) Capital work-in-progress

0.000

0.000

0.000

(iv) Intangible assets under development

0.000

0.000

0.000

(b) Non-current Investments

0.139

0.246

0.230

(c) Deferred tax assets (net)

0.197

0.138

0.059

(d)  Long-term Loan and Advances

0.449

1.140

0.592

(e) Other Non-current assets

0.000

0.000

5.187

Total Non-Current Assets

31.881

28.359

33.818

 

 

 

 

(2) Current assets

 

 

 

(a) Current investments

0.000

0.000

0.000

(b) Inventories

16.056

19.191

7.474

(c) Trade receivables

184.881

157.685

163.950

(d) Cash and cash equivalents

1.781

1.250

0.132

(e) Short-term loans and advances

17.641

10.111

8.190

(f) Other current assets

0.000

0.000

0.000

Total Current Assets

220.359

188.237

179.746

 

 

 

 

TOTAL

252.240

216.596

213.564

 

 

PROFIT & LOSS ACCOUNT

 

 

PARTICULARS

31.03.2013

31.03.2012

31.03.2011

 

SALES

 

 

 

 

 

Income

610.409

457.079

402.813

 

 

Other Income

10.363

7.844

7.314

 

 

TOTAL                                         (A)

620.772

464.923

410.127

 

 

 

 

 

Less

EXPENSES

 

 

 

 

 

Cost of Materials Consumed

592.244

458.074

 

 

Purchase of Stock-in-trade

3.135

(11.717)

 

 

 

Changes in Inventories of finished goods, work-in-progress and stock-in-trade

5.200

3.371

 

 

 

Employee Benefits Expenses

3.923

4.809

 

 

 

TOTAL                                         (B)

604.502

454.537

400.445

 

 

 

 

 

 

PROFIT/(LOSS) BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION (A-B)     (C)

16.270

10.386

9.682

 

 

 

 

 

Less

FINANCIAL EXPENSES                                    (D)

0.693

0.736

1.077

 

 

 

 

 

 

PROFIT/(LOSS) BEFORE TAX, DEPRECIATION AND AMORTISATION (C-D)                                (E)

15.577

9.650

8.605

 

 

 

 

 

Less

DEPRECIATION/ AMORTISATION                     (F)

1.032

1.093

1.290

 

 

 

 

 

 

PROFIT/(LOSS) BEFORE TAX (E-F)                  (G)     

14.545

8.557

7.315

 

 

 

 

 

 

TAX                                                                  (H)

4.938

0.778

0.000

 

 

 

 

 

 

PROFIT/(LOSS) AFTER TAX (G-H)                    (I)

9.726

7.936

7.315

 

 

 

 

 

 

Earnings / (Loss) Per Share (Rs.)

46.97

NA

NA

 

 

 

 

KEY RATIOS

 

PARTICULARS

 

 

31.03.2013

31.03.2012

31.03.2011

Net Profit Margin

(PAT/Sales)

(%)

1.59

1.74

1.82

 

 

 

 

 

Operating Profit Margin

(PBIDT/Sales)

(%)

2.67

2.27

2.40

 

 

 

 

 

Return on Total Assets

(PBT/Total Assets}

(%)

5.77

3.96

3.43

 

 

 

 

 

Return on Investment (ROI)

(PBT/Networth)

 

0.25

0.18

0.19

 

 

 

 

 

Debt Equity Ratio

(Total Debt /Networth)

 

0.21

0.35

0.52

 

 

 

 

 

Current Ratio

(Current Asset/Current Liability)

 

1.14

1.11

1.16

 

 

FINANCIAL ANALYSIS

[all figures are in Rupees Millions]

 

DEBT EQUITY RATIO

 

Particular

31.03.2011

31.03.2012

31.03.2013

 

Rs. In Millions

Rs. In Millions

Rs. In Millions

Share Capital

1.900

1.900

2.071

Reserves & Surplus

36.340

44.275

57.244

Share Application money pending allotment

0.467

0.967

0.000

Net worth

38.707

47.142

59.315

 

 

 

 

Long Term borrowings

19.516

0.000

0.000

Short Term borrowings

0.571

16.681

12.469

Total borrowings

20.087

16.681

12.469

Debt/Equity ratio

0.519

0.354

0.210

 

 

 

 

YEAR-ON-YEAR GROWTH

 

Year on Year Growth

31.03.2011

31.03.2012

31.03.2013

 

Rs. In Millions

Rs. In Millions

Rs. In Millions

Sales

402.813

457.079

610.409

 

 

13.472

33.546

 

 

 

 

 

 

NET PROFIT MARGIN

 

Net Profit Margin

31.03.2011

31.03.2012

31.03.2013

 

Rs. In Millions

Rs. In Millions

Rs. In Millions

Sales

402.813

457.079

610.409

Profit

7.315

7.936

9.726

 

1.82%

1.74%

1.59%

 

 

 

 

LOCAL AGENCY FURTHER INFORMATION

 

Sr. No.

Check List by Info Agents

Available in Report (Yes / No)

1]

Year of Establishment

Yes

2]

Locality of the firm

Yes

3]

Constitutions of the firm

Yes

4]

Premises details

No

5]

Type of Business

Yes

6]

Line of Business

Yes

7]

Promoter's background

Yes

8]

No. of employees

Yes

9]

Name of person contacted

Yes

10]

Designation of contact person

Yes

11]

Turnover of firm for last three years

Yes

12]

Profitability for last three years

Yes

13]

Reasons for variation <> 20%

-----------

14]

Estimation for coming financial year

No

15]

Capital in the business

Yes

16]

Details of sister concerns

Yes

17]

Major suppliers

No

18]

Major customers

No

19]

Payments terms

Yes

20]

Export / Import details (if applicable)

No

21]

Market information

----------

22]

Litigations that the firm / promoter involved in

----------

23]

Banking Details

Yes

24]

Banking facility details

Yes

25]

Conduct of the banking account

----------

26]

Buyer visit details

----------

27]

Financials, if provided

Yes

28]

Incorporation details, if applicable

Yes

29]

Last accounts filed at ROC

Yes

30]

Major Shareholders, if available

Yes

31]

Date of Birth of Proprietor/Partner/Director, if available

Yes

32]

PAN of Proprietor/Partner/Director, if available

No

33]

Voter ID No of Proprietor/Partner/Director, if available

No

34]

External Agency Rating, if available

No

 

 

BACKGROUND

 

The company is in the business of trading in bulk drugs and pharmaceuticals products of various types and also indenting agents for pharmaceutical companies situated in India. During the year, the major source of revenue in from sale of pharma products and commission and service charges in indenting.  

 

PERFORMANCE

 

During the year the revenue from operations was Rs.610.409 Millions as against Rs.457.079 Millions in the previous year. The other income was Rs.10.363 Millions as against Rs.7.844 Millions in the previous year. The total expenses was Rs.606.227 Millions as against Rs.456.366 Millions in the previous year. The provision for taxation is Rs.4.938 Millions for the current year. The profit after tax is Rs.9.726 Millions as against profit after tax in the previous year which was rs.7.936 Millions. The company is constructing a building in Ekkatuthangal which will be used for exploring various business activities.

 

Due to the steps taken by the board of directors the administrative expenses was curbed to an extent, and also the company was maintained its growth of profit and its hopeful that it will maintain the same in the years to come. The pharma industry has its industry will perform well in the years to come. 

 

 

INDEX OF CHARGE:

 

Sr. No.

Charge ID

Date of Charge Creation/Modification

Charge amount secured

Charge Holder

Address

Service Request Number (SRN)

1

10510884

23/07/2014 *

55,000,000.00

ICICI Bank Limited

New No.69, Old No.13 A, Jawaharlal Nehru Road, Ekkatuthangal, Chennai, Tamil Nadu - 600032, India

C13307871

2

10383427

16/10/2012

6,000,000.00

ICICI BANK LIMITED

Landmarkrace Cource Circle, Alkapuri, Baroda, Gujarat - 390015, India

B60883287

*Date of modification Charges

 

 

FIXED ASSETS:

 

·         Land

·         Building

·         Plant and Machinery

·         Computer

·         Vehicles

·         Furniture and Fixture

 

 

 

 


CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                                       None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                        None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                        None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 


 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.61.55

UK Pound

1

Rs.97.53

Euro

1

Rs.76.48

 

 

INFORMATION DETAILS

 

Information Gathered by :

DIP

 

 

Analysis Done by :

RAS

 

 

Report Prepared by :

VNT


 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

6

PAID-UP CAPITAL

1~10

5

OPERATING SCALE

1~10

5

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

5

--PROFITABILIRY

1~10

5

--LIQUIDITY

1~10

5

--LEVERAGE

1~10

5

--RESERVES

1~10

6

--CREDIT LINES

1~10

5

--MARGINS

-5~5

--

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

NO

--AFFILIATION

YES/NO

YES

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

DEFAULTER

 

 

--RBI

YES/NO

NO

--EPF

YES/NO

NO

 

 

 

TOTAL

 

47

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                  Payment record (10%)

Credit history (10%)                   Market trend (10%)                                Operational size (10%)

 


 

RATING EXPLANATIONS

 

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

NB

NEW BUSINESS

 

 

 

 

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.